These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17329867)

  • 1. DNA/Lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts.
    Hattori Y; Maitani Y
    Biol Pharm Bull; 2007 Mar; 30(3):603-7. PubMed ID: 17329867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells.
    Hattori Y; Ding WX; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):122-30. PubMed ID: 17512626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile.
    Shen X; Falzon M
    Mol Cell Endocrinol; 2003 Jan; 199(1-2):165-77. PubMed ID: 12581888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice.
    Salvi A; Arici B; Alghisi A; Barlati S; De Petro G
    Tumour Biol; 2007; 28(1):16-26. PubMed ID: 17159381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation.
    Mikata K; Uemura H; Ohuchi H; Ohta S; Nagashima Y; Kubota Y
    Mol Cancer Ther; 2002 Feb; 1(4):247-52. PubMed ID: 12467220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
    Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
    J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of integrin subunits in DU-145/AR prostate cancer cells.
    Nagakawa O; Akashi T; Hayakawa Y; Junicho A; Koizumi K; Fujiuchi Y; Furuya Y; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2004 Oct; 12(4):837-41. PubMed ID: 15375509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y; Chen N; Yu HJ; Dong XP; Huang QH
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.
    Gong J; Wang D; Sun L; Zborowska E; Willson JK; Brattain MG
    Cell Growth Differ; 1997 Jan; 8(1):83-90. PubMed ID: 8993837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pro-adhesive and pro-survival effects of glucocorticoid in human ovarian cancer cells.
    Yin L; Fang F; Song X; Wang Y; Huang G; Su J; Hui N; Lu J
    J Mol Endocrinol; 2016 Jul; 57(1):61-72. PubMed ID: 27151574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytes.
    Webersinke G; Bauer H; Amberger A; Zach O; Bauer HC
    Biochem Biophys Res Commun; 1992 Dec; 189(2):877-84. PubMed ID: 1282001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient transfer of reporter gene-loaded nanoparticles to bone marrow stromal cells (D1) by reverse transfection.
    Nguyen YT; Kim HK; Kwon JS; Kim YS; Yoon TR; Ahn Y; Jeong MH; Park IK
    J Nanosci Nanotechnol; 2010 May; 10(5):3170-4. PubMed ID: 20358915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Availability of pDNA and mRNA after Transfection: A Comparative Study among Polyplexes, Lipoplexes, and Lipopolyplexes.
    Gonçalves C; Akhter S; Pichon C; Midoux P
    Mol Pharm; 2016 Sep; 13(9):3153-63. PubMed ID: 27486998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
    Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.